Want to see JP:6823 full AI Analyst Report?
6823 Stock Chart & Stats
¥2691.00
-¥68.00(-2.64%)
At close: 4:00 PM EST
¥2691.00
-¥68.00(-2.64%)
Day’s Range― - ―
52-Week Range¥2,480.00 - ¥4,160.00
Previous CloseN/A
Volume32.10K
Average Volume (3M)26.46K
Market Cap
¥44.20B
Enterprise Value¥37.98B
Total Cash (Recent Filing)¥8.56B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)13.2
Beta1.10
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.93%
Share Statistics
EPS (TTM)271.40
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)0.96
Price to Sales (P/S)1.17
P/FCF Ratio9.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)283.9
Revenue Forecast (FY)¥30.00B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetNear-zero total debt and steadily compounding equity provide durable financial resilience. Low leverage reduces refinancing and interest-rate risk, preserves flexibility to fund R&D, capex, or dividends, and supports stability through industrial or medical demand cycles.
Sustained Revenue GrowthMulti-year top-line expansion, including a sharp 2026 uptick, reflects durable demand across measurement and hearing product lines. Consistent revenue scale supports product development, market penetration, and steadier long-term earnings generation across business cycles.
Improving Cash GenerationRising operating and free cash flow underpin the company's ability to self-fund investments, service stakeholders, and maintain optionality. The recent rebound demonstrates capacity to convert profit into cash, supporting sustainable operations and strategic reinvestment.
Bears Say
Free Cash Flow VolatilityMaterial swings in FCF across years indicate exposure to working-capital cycles or lumpy investment spending. Persistent volatility can constrain consistent capital allocation, make forecasting harder, and reduce the reliability of cash for dividends or strategic initiatives over the medium term.
Margin Visibility / Cost PressureSigns of weaker gross profit dollars amid rising revenue suggest margin pressure from costs, pricing, or mix shifts. If structural, compressed margins would limit net income upside from revenue growth and reduce returns on incremental investment over the coming quarters.
Hardware-Centric Revenue MixHeavy reliance on hardware and one-time system sales exposes revenue to industrial and medical capex cycles and limits recurring revenue. This structural mix increases sensitivity to customer spending swings and constrains long-term predictability compared with subscription or service-heavy models.
Rion Co., Ltd. News
6823 FAQ
What was Rion Co., Ltd.’s price range in the past 12 months?
Rion Co., Ltd. lowest stock price was ¥2480.00 and its highest was ¥4160.00 in the past 12 months.
What is Rion Co., Ltd.’s market cap?
Rion Co., Ltd.’s market cap is ¥44.20B.
When is Rion Co., Ltd.’s upcoming earnings report date?
Rion Co., Ltd.’s upcoming earnings report date is Jul 30, 2026 which is in 16 days.
How were Rion Co., Ltd.’s earnings last quarter?
Rion Co., Ltd. released its earnings results on Apr 28, 2026. The company reported ¥88.99 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Rion Co., Ltd. overvalued?
According to Wall Street analysts Rion Co., Ltd.’s price is currently Overvalued.
Does Rion Co., Ltd. pay dividends?
Rion Co., Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 2.93%. See more information on Rion Co., Ltd. dividends here
What is Rion Co., Ltd.’s EPS estimate?
Rion Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rion Co., Ltd. have?
Rion Co., Ltd. has 12,347,700 shares outstanding.
What happened to Rion Co., Ltd.’s price movement after its last earnings report?
Rion Co., Ltd. reported an EPS of ¥88.99 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.772%.
Which hedge fund is a major shareholder of Rion Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6823
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rion Co., Ltd.
Rion Co., Ltd. develops, manufactures, sells, and services particle counters, medical equipment, and environmental equipment in Japan. The company’s audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom-made, and analog body aid instruments, as well as wireless and waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and recorders, and other products. The company’s particle counters comprise air and liquid-borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---